Capital Fund Management (CFM)’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,200
Closed -$503K 1732
2022
Q4
$503K Buy
+11,200
New +$507K ﹤0.01% 1276
2021
Q1
Sell
-35,500
Closed -$3.4M 1604
2020
Q4
$3.4M Buy
+35,500
New +$3.66M 0.03% 602
2019
Q3
Sell
-40,200
Closed -$2.59M 1891
2019
Q2
$2.59M Buy
+40,200
New +$2.59M 0.02% 724
2019
Q1
Sell
-6,400
Closed -$243K 2086
2018
Q4
$243K Buy
+6,400
New +$226K ﹤0.01% 1683

Other funds holding TNDM

Capital Fund Management (CFM)'s TNDM Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 38,400 shares — an estimated $844K sold.

Capital Fund Management (CFM) first reported a position in TNDM in Q2 2019 and held it in 21 quarters. The position peaked at $13M in Q4 2022. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 38,400 Tandem Diabetes Care shares in Q1 2026, an estimated $844K.
  • Capital Fund Management (CFM) first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 21 quarters.
  • Capital Fund Management (CFM)'s Tandem Diabetes Care position peaked at $13M in Q4 2022.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.